These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 19846588)

  • 1. Inhibition of delayed-type hypersensitivity by Cucurbitacin R through the curbing of lymphocyte proliferation and cytokine expression by means of nuclear factor AT translocation to the nucleus.
    Escandell JM; Recio MC; Giner RM; Máñez S; Cerdá-Nicolás M; Merfort I; Ríos JL
    J Pharmacol Exp Ther; 2010 Feb; 332(2):352-63. PubMed ID: 19846588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydrocucurbitacin B inhibits delayed type hypersensitivity reactions by suppressing lymphocyte proliferation.
    Escandell JM; Recio MC; Máñez S; Giner RM; Cerdá-Nicolás M; Gil-Benso R; Ríos JL
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1261-8. PubMed ID: 17562851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demethylnobiletin inhibits delayed-type hypersensitivity reactions, human lymphocyte proliferation and cytokine production.
    Bas E; Recio MC; Giner RM; Máñez S; López-Ginés C; Gil-Benso R; Ríos JL
    Br J Pharmacol; 2007 Dec; 152(8):1272-82. PubMed ID: 17934513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cucurbitacin R reduces the inflammation and bone damage associated with adjuvant arthritis in lewis rats by suppression of tumor necrosis factor-alpha in T lymphocytes and macrophages.
    Escandell JM; Recio MC; Máñez S; Giner RM; Cerdá-Nicolás M; Ríos JL
    J Pharmacol Exp Ther; 2007 Feb; 320(2):581-90. PubMed ID: 17065367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insight into the inhibition of the inflammatory response to experimental delayed-type hypersensitivity reactions in mice by scropolioside A.
    Bas E; Recio MC; Máñez S; Giner RM; Escandell JM; López-Ginés C; Ríos JL
    Eur J Pharmacol; 2007 Jan; 555(2-3):199-210. PubMed ID: 17113578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the pro-inflammatory mediators' production and anti-inflammatory effect of the iridoid scrovalentinoside.
    Bas E; Recio MC; Abdallah M; Máñez S; Giner RM; Cerdá-Nicolás M; Ríos JL
    J Ethnopharmacol; 2007 Apr; 110(3):419-27. PubMed ID: 17112695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis.
    Saso Y; Conner EM; Teegarden BR; Yuan CS
    J Pharmacol Exp Ther; 2001 Jan; 296(1):106-12. PubMed ID: 11123369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germinated black soybean fermented with Lactobacillus pentosus SC65 alleviates DNFB-induced delayed-type hypersensitivity in C57BL/6N mice.
    Lee HJ; Cho HE; Park HJ
    J Ethnopharmacol; 2021 Jan; 265():113236. PubMed ID: 32750462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation.
    Wang JX; Tang W; Shi LP; Wan J; Zhou R; Ni J; Fu YF; Yang YF; Li Y; Zuo JP
    Br J Pharmacol; 2007 Mar; 150(5):652-61. PubMed ID: 17262016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DTH effector response and IL-2 are unaffected by cyclosporine A in autoimmune B6D2F1 mice.
    MacLeod H; Goodwin DG; Damphousse C; Lonie E; Xu X; Collins M; Nickerson-Nutter CL
    Cell Immunol; 2010; 266(1):14-23. PubMed ID: 20851384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (5R)-5-hydroxytriptolide (LLDT-8), a novel triptolide analog mediates immunosuppressive effects in vitro and in vivo.
    Zhou R; Zhang F; He PL; Zhou WL; Wu QL; Xu JY; Zhou Y; Tang W; Li XY; Yang YF; Li YC; Zuo JP
    Int Immunopharmacol; 2005 Dec; 5(13-14):1895-903. PubMed ID: 16275624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel artemisinin derivative, 3-(12-beta-artemisininoxy) phenoxyl succinic acid (SM735), mediates immunosuppressive effects in vitro and in vivo.
    Zhou WL; Wu JM; Wu QL; Wang JX; Zhou Y; Zhou R; He PL; Li XY; Yang YF; Zhang Y; Li Y; Zuo JP
    Acta Pharmacol Sin; 2005 Nov; 26(11):1352-8. PubMed ID: 16225758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive effects of fisetin on mice T lymphocytes in vitro and in vivo.
    Song B; Guan S; Lu J; Chen Z; Huang G; Li G; Xiong Y; Zhang S; Yue Z; Deng X
    J Surg Res; 2013 Nov; 185(1):399-409. PubMed ID: 23993202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UR-1505, a new salicylate, blocks T cell activation through nuclear factor of activated T cells.
    Román J; de Arriba AF; Barrón S; Michelena P; Giral M; Merlos M; Bailón E; Comalada M; Gálvez J; Zarzuelo A; Ramis I
    Mol Pharmacol; 2007 Aug; 72(2):269-79. PubMed ID: 17475810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive activity of pogostone on T cells: Blocking proliferation via S phase arrest.
    Su JY; Luo X; Zhang XJ; Deng XL; Su ZR; Zhou L; Li SS; Dai Z; Xu Y; Lai XP
    Int Immunopharmacol; 2015 Jun; 26(2):328-37. PubMed ID: 25912345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-2 is a negative regulator of interleukin-1beta secretion in murine macrophages in pharmacological-induced apoptosis.
    Escandell JM; Recio MC; Giner RM; Máñez S; Ríos JL
    Br J Pharmacol; 2010 Aug; 160(7):1844-56. PubMed ID: 20649584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of T lymphocyte activation by 3-chloro-1,2-propanediol mono- and di-palmitate esters in vitro.
    Huang G; Xue J; Sun X; Wang J; Wang Y; Wang TTY; Liangli LY
    Toxicol In Vitro; 2018 Sep; 51():54-62. PubMed ID: 29733892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory properties of an isoxazole derivative - MZO-2.
    Mączyński M; Artym J; Kocięba M; Kochanowska I; Ryng S; Zimecki M
    Pharmacol Rep; 2016 Oct; 68(5):894-902. PubMed ID: 27351945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of effects of farrerol on suppression of murine T lymphocyte activation in vitro and in vivo.
    Xiong Y; Zhang S; Lu J; Sun S; Song B; Xu L; Yang Z; Guan S
    Int Immunopharmacol; 2013 Jun; 16(2):313-21. PubMed ID: 23619554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3/STAT5 signalling pathway.
    Liu Y; Yang T; Li H; Li MH; Liu J; Wang YT; Yang SX; Zheng J; Luo XY; Lai Y; Yang P; Li LM; Zou Q
    Br J Pharmacol; 2013 Feb; 168(3):632-43. PubMed ID: 22906008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.